Calyxt, Inc. (CLXT)
Price:
6.30 USD
( + 0.33 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Lancaster Colony Corporation
VALUE SCORE:
0
2nd position
The Simply Good Foods Company
VALUE SCORE:
10
The best
J&J Snack Foods Corp.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
NEWS
CALYXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. – CLXT
headlinesoftoday.com
2023-03-09 22:08:00NEW ORLEANS, March 9, 2023 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Calyxt, Inc. (“the Company”) (NasdaqCM: CLXT) with Cibus pursuant to which Calyxt shareholders will own approximately 5% of the combined company. […]...
What Penny Stocks Trends Can Help You Profit in 2023?
pennystocks.com
2023-01-18 06:00:00How to make money with penny stocks in 2023 The post What Penny Stocks Trends Can Help You Profit in 2023? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Watch After Big News This Week
pennystocks.com
2023-01-17 09:24:14Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Calyxt (CLXT) Stock Up 140% Today?
investorplace.com
2023-01-17 08:10:29Calyxt (NASDAQ: CLXT ) stock is rocketing higher on Tuesday after the company signed a merger agreement with Cibus Global. Calyxt and Cibus Global both operate in the agriculture-based gene editing sector.
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
prnewswire.com
2023-01-17 06:30:00– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients – – Upon closure of the merger, Rory Riggs, Cibus Co-Founder, will become C hief Executive Officer and Chairman of the combined company and the Cibus leadership team will lead the new organization – ROSEVILLE, Minn. and SAN DIEGO , Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today announced that both companies have entered into a definitive merger agreement under which Calyxt and Cibus will merge in an all-stock transaction.
Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript
seekingalpha.com
2022-11-06 11:07:10Calyxt, Inc. (NASDAQ:CLXT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Calyxt Third Quarter 2022 Financial Results and Corporate Update Conference Call and Webcast.
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
zacks.com
2022-11-03 18:48:30Calyxt (CLXT) delivered earnings and revenue surprises of 13.33% and 86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-08-07 13:45:05Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
prnewswire.com
2022-07-28 07:00:00ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-07-21 07:00:00ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30 p.m.
Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-08 03:07:11Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-04-21 07:08:00ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.
Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down
seekingalpha.com
2022-04-01 02:18:39Calyxt is now on to its third business plan, pivoting from gene-edited seed traits to synthetic biology. The company is looking to produce molecules of interest to pharmaceutical, nutraceutical, and cosmeceutical companies through sustainable plant-based technology.
Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-03-03 23:19:04Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
Calyxt (CLXT) Reports Q4 Loss, Misses Revenue Estimates
zacks.com
2022-03-03 19:10:34Calyxt (CLXT) delivered earnings and revenue surprises of 17.39% and 42.28%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-02-24 07:00:00ROSEVILLE, Minn., Feb. 24, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will hold a conference call on Thursday, March 3, 2022, at 4:30 p.m.
No data to display
CALYXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. – CLXT
headlinesoftoday.com
2023-03-09 22:08:00NEW ORLEANS, March 9, 2023 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Calyxt, Inc. (“the Company”) (NasdaqCM: CLXT) with Cibus pursuant to which Calyxt shareholders will own approximately 5% of the combined company. […]...
What Penny Stocks Trends Can Help You Profit in 2023?
pennystocks.com
2023-01-18 06:00:00How to make money with penny stocks in 2023 The post What Penny Stocks Trends Can Help You Profit in 2023? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Watch After Big News This Week
pennystocks.com
2023-01-17 09:24:14Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Calyxt (CLXT) Stock Up 140% Today?
investorplace.com
2023-01-17 08:10:29Calyxt (NASDAQ: CLXT ) stock is rocketing higher on Tuesday after the company signed a merger agreement with Cibus Global. Calyxt and Cibus Global both operate in the agriculture-based gene editing sector.
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
prnewswire.com
2023-01-17 06:30:00– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients – – Upon closure of the merger, Rory Riggs, Cibus Co-Founder, will become C hief Executive Officer and Chairman of the combined company and the Cibus leadership team will lead the new organization – ROSEVILLE, Minn. and SAN DIEGO , Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today announced that both companies have entered into a definitive merger agreement under which Calyxt and Cibus will merge in an all-stock transaction.
Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript
seekingalpha.com
2022-11-06 11:07:10Calyxt, Inc. (NASDAQ:CLXT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Calyxt Third Quarter 2022 Financial Results and Corporate Update Conference Call and Webcast.
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
zacks.com
2022-11-03 18:48:30Calyxt (CLXT) delivered earnings and revenue surprises of 13.33% and 86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-08-07 13:45:05Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
prnewswire.com
2022-07-28 07:00:00ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-07-21 07:00:00ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30 p.m.
Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-08 03:07:11Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-04-21 07:08:00ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.
Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down
seekingalpha.com
2022-04-01 02:18:39Calyxt is now on to its third business plan, pivoting from gene-edited seed traits to synthetic biology. The company is looking to produce molecules of interest to pharmaceutical, nutraceutical, and cosmeceutical companies through sustainable plant-based technology.
Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-03-03 23:19:04Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
Calyxt (CLXT) Reports Q4 Loss, Misses Revenue Estimates
zacks.com
2022-03-03 19:10:34Calyxt (CLXT) delivered earnings and revenue surprises of 17.39% and 42.28%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time
prnewswire.com
2022-02-24 07:00:00ROSEVILLE, Minn., Feb. 24, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will hold a conference call on Thursday, March 3, 2022, at 4:30 p.m.